Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda

Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda.

Perspectives Tuberculosis is a disease of poverty that claims the lives of over a million people annually. 1 Globally, tuberculosis is concentrated in low-to middle-income countries. The five countries – Brazil, the Russian Federation, India, China and South Africa – that make up the BRICS group account for 46% of all incident cases of tuberculosis and 40% of all tuberculosis-related mortality....

Post-2015 agenda strategies for tuberculosis control in Brazil: challenges and opportunities.

Lessons and Leadership in Health; Comment on “Improving the World’s Health through the Post-2015 Development Agenda: Perspectives from Rwanda”

This paper comments on the principles that informed Rwanda’s successful efforts to adapt its health system to population needs, and more specifically to reduce health inequities. The point is made that these may be universally applicable for countries as they deal with the challenges of post-2015 health agenda.

Sustaining Health for Wealth: Perspectives for the Post-2015 Agenda; Comment on “Improving the World’s Health Through the Post-2015 Development Agenda: Perspectives From Rwanda”

The sustainable development goals (SDGs) offer a unique opportunity for policy-makers to build on the millennium development goals (MDGs) by adopting more sustainable approaches to addressing global development challenges. The delivery of health services is of particular concern. Most African countries are unlikely to achieve the health MDGs, however, significant progress has been made particul...

Essential Drugs Production in Brazil, Russia, India, China and South Africa (BRICS): Opportunities and Challenges

The objective of this work is to elucidate various essential drugs in the Brazil, Russia, India, China and South Africa (BRICS) countries. It discusses the opportunities and challenges of the existing biotech infrastructure and the production of drugs and vaccines in member states of the BRICS. This research is based on a systematic literature review between the years 2000 and 2014 of documents...